Dr. Torous and Dr. Nguyen are with the Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston. Dr. Chan is with the Department of Medicine, University of California, San Francisco (UCSF). Dr. Gipson and Dr. Kim are with the Department of Psychiatry, Children's Hospital Boston, Boston. Dr. Luo is with the Department of Psychiatry, University of California, Riverside. Dr. Wang is with the Division of Research, American Psychiatric Association, Washington, D.C. Dror Ben-Zeev, Ph.D., is editor of this column.
Psychiatr Serv. 2018 May 1;69(5):498-500. doi: 10.1176/appi.ps.201700423. Epub 2018 Feb 15.
With thousands of smartphone apps targeting mental health, it is difficult to ignore the rapidly expanding use of apps in the treatment of psychiatric disorders. Patients with psychiatric conditions are interested in mental health apps and have begun to use them. That does not mean that clinicians must support, endorse, or even adopt the use of apps, but they should be prepared to answer patients' questions about apps and facilitate shared decision making around app use. This column describes an evaluation framework designed by the American Psychiatric Association to guide informed decision making around the use of smartphone apps in clinical care.
随着数以千计的针对精神健康的智能手机应用程序的出现，精神障碍治疗中应用程序的快速扩展使用已不容忽视。患有精神疾病的患者对精神健康应用程序很感兴趣，并已开始使用它们。这并不意味着临床医生必须支持、认可甚至采用应用程序的使用，但他们应该准备好回答患者有关应用程序的问题，并促进围绕应用程序使用的共同决策。本专栏描述了美国精神病学协会设计的一个评估框架，旨在指导在临床护理中使用智能手机应用程序的决策。
